Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia.

@article{Dazzi2000DurabilityOR,
  title={Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia.},
  author={Francesco Dazzi and Richard M. Szydlo and Nicholas C. P. Cross and Charles G. Craddock and Jaspal S Kaeda and Ed Kanfer and Kate Cwynarski and Eduardo Olavarr{\'i}a and A Yong and Jane F Apperley and John M. Goldman},
  journal={Blood},
  year={2000},
  volume={96 8},
  pages={
          2712-6
        }
}
An analysis was performed of the response to treatment with donor lymphocyte infusions (DLI) and the survival in 66 consecutive patients who relapsed after primary treatment by allogeneic stem cell transplantation for BCR-ABL-positive chronic myeloid leukemia. The transplant donor was an HLA-identical sibling (n = 35) or a "matched" unrelated volunteer (n = 31). Fifty-seven patients were transplanted in chronic phase, eight in accelerated phase, and one in second chronic phase. The recognition… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 119 CITATIONS, ESTIMATED 59% COVERAGE

2 The Graft vs Leukemia Effect

VIEW 1 EXCERPT
CITES BACKGROUND

FILTER CITATIONS BY YEAR

2001
2019

CITATION STATISTICS

  • 2 Highly Influenced Citations

References

Publications referenced by this paper.
SHOWING 1-10 OF 28 REFERENCES

Long-term follow-up of patients who achieved complete remission after donor leukocyte infusions

DL Porter, RH JrCollins, O Shpilberg
  • Biol Blood Marrow Transplant
  • 1999

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 1997